SCHEMBL7693188

SCHEMBL7693188

N#Cc1cc(F)c(N=C=S)cc1F

nearest known ligand 0.47

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TRPV4 Q9HBA0 2/20 0.47
KHK P50053 1/20 0.33
CYP11B1 P15538 2/20 0.31
CYP11B2 P19099 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6722274 0.84 TRPV4 (0.35) TRPV4KHK
SCHEMBL12528259 0.81 AR (0.40) TRPV4
SCHEMBL6594425 0.81 TRPV4 (0.47) TRPV4KHKCYP11B1CYP11B2
SCHEMBL1725294 0.80 TRPV4 (0.39) TRPV4KHKCYP11B1CYP11B2
SCHEMBL1399737 0.79 ABCB11 (0.34)
SCHEMBL7490441 0.76 CYP11B1 (0.38) CYP11B1CYP11B2
SCHEMBL6651303 0.76 TRPV4 (0.71) TRPV4KHKCYP11B1CYP11B2
SCHEMBL7688191 0.72 PGR (0.40)
SCHEMBL11552834 0.72 KDM1A (0.36)
SCHEMBL546939 0.72 TRPV4 (0.37) TRPV4KHK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2475647-B1 ANDROGEN RECEPTOR ANTAGONISTS AND USES THEREOF SUZHOU KINTOR PHARMACEUTICALS INC (CN) 2015-11-04 EP disclosed
US-8809550-B2 Androgen receptor antagonists and uses thereof SUZHOU KINTOR PHARMACEUTICALS, INC. (CN) 2014-08-19 US disclosed
US-20120172406-A1 ANDROGEN RECEPTOR ANTAGONISTS AND USES THEREOF Tong, Youzhi (CN) 2012-07-05 US disclosed
WO-2011029392-A1 ANDROGEN RECEPTOR ANTAGONISTS AND USES THEREOF TONG YOUZHI (CN) 2011-03-17 WO disclosed
US-6339044-B1 USEFUL AS HERBICIDES AND INSECTICIDES BAYER AKTIENGESELLSCHAFT 2002-01-15 US disclosed
EP-1164128-A1 4-Cyanophenyliminoheterocycles BAYER AG (DE) 2001-12-19 EP disclosed
US-5756805-A CHEMICAL INTERMEDIATES FOR HERBICIDES BAYER AKTIENGESELLSCHAFT (DE) 1998-05-26 US disclosed
EP-0736014-A1 N-CYANOARYL NITROGEN HETEROCYCLES WITH SULPHUR-CONTAINING GROUPINGS BAYER AG (DE) 1996-10-09 EP disclosed
WO-1995017391-A1 N-CYANOARYL NITROGEN HETEROCYCLES WITH SULPHUR-CONTAINING GROUPINGS BAYER AKTIENGESELLSCHAFT (DE) 1995-06-29 WO disclosed
EP-0648772-A1 4-Cyanophenylheterocycles BAYER AG (DE) 1995-04-19 EP disclosed
US-4138242-A Novel 2-aryl-2,3,5,6,7,8-hexahydro-3-thioxoimidazo-[1,5-a-]pyridin-1(BaH)-ones as herbicides E. I. DU PONT DE NEMOURS AND COMPANY (US) 1979-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120172406-A1 ANDROGEN RECEPTOR ANTAGONISTS AND USES THEREOF AR, SHBG, MUSK TRPV4 825/4885KHK 2104/4885CYP11B1 58/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.